Vertex Reports Success In Second Major Hepatitis Drug Study
August 10th, 2010
By Thomas Gryta Of DOW JONES NEWSWIRES NEW YORK (Dow Jones)--Vertex Pharmaceuticals Inc. (VRTX) reported the success of the second of three key late-stage studies of hepatitis-C treatment, telaprevir, essentially curing 72% of patients using the drug. ...
See all stories on this topic » Health news @ read more
See all stories on this topic » Health news @ read more
Posted in Health News | 
Tags: daily news health, Dow Jones, Dow Jones Newswires, health in news, Health Information, health insurance news, Health News, health news today, health science news, health world news, healthy food, Healthy Food Choices, Hepatitis, Hepatitis C, Hepatitis C Treatment, Hepatitis Treatment, medical health news, public health news, Success, Vertex Pharmaceuticals Inc, Vrtx
Random Health posts
- Red tea: Even better for you than green tea?
- Look good for the summer holidays
- Daisy's Campaign Diary: Local leadership on public health
- High School Concession Stands being watched by Health Inspectors
- Should organic foods have synthetic vitamins?
- Tessa Prieto-Valdez's Anti-aging Tips
- Advancements In Anti-Aging Skin Care Products | Health For World
- Janet Murguía: Health Care Reform is 90 Days Old -- Now What?
- BBC News Vitamin Bputs off Alzheimer's
- Health, Food Safety Has Families Going Organic
